Wuhan General Group China Inc.

OTC: WUHN

Company Overview

Wuhan General Group, Inc. through its wholly-owned subsidiary MJ MedTech is a nutraceutical biotechnology company that researches, develops and commercializes a range of CBD-based products under the Dr. AnnaRx™ and Medspresso™ brands. In addition, its new wholly-owned division, M2Bio is researching and developing indications for new Psilocybin therapies that will help patients who suffer from mental illness, Alzheimer and Parkinson disease.

The company's mission is to advance botanical-based medicine to the forefront by deploying best-practice science and medicine, clinical research, and emerging technologies.

Management Team

Ms. Carol Pan
Principal Financial Officer, Principal Accounting Officer and Treasurer

Mr. Jeffrey Robinson
Chairman & CEO

Dr. Hyder Ali Khoja
Chief Scientific Officer

Dr. Anna Leralta Morera
Chief Medical Officer

Mr. Luka Marjanovic
Head of Product Devel. for the MJ MedTech in South Africa

Sign Up for Alerts

Receive an email alert every time a company announces a merger, capital raise or files for an IPO.

Key Highlights

Market Capitalization
$2,806,208

Shares Outstanding
33,926,500